(Q37896546)

25 August 2017

1 reference

title

Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis (English)

1 reference

25 August 2017

0 references

Karen E Hansen

1

1 reference

25 August 2017

H Alexander Wilson

2

1 reference

25 August 2017

Carol Zapalowski

3

1 reference

25 August 2017

Howard A Fink

4

1 reference

25 August 2017

Salvatore Minisola

5

1 reference

25 August 2017

Robert A Adler

6

1 reference

25 August 2017

publication date

30 June 2011

1 reference

Journal of Bone and Mineral Research

25 August 2017

published in

1 reference

25 August 2017

volume

26

1 reference

25 August 2017

issue

9

1 reference

25 August 2017

page(s)

1989-1996

1 reference

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

25 August 2017

cites work

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

The appropriateness method

21 January 2018

1 reference

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

21 January 2018

1 reference

Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study.

21 January 2018

1 reference

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

21 January 2018

1 reference

Management of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

21 January 2018

1 reference

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

21 January 2018

1 reference

Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy

21 January 2018

1 reference

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

21 January 2018

1 reference

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

21 January 2018

1 reference

21 January 2018

1 reference

Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization.

21 January 2018

1 reference

Appropriateness criteria for surgery improve clinical outcomes in patients with low back pain and/or sciatica.

21 January 2018

1 reference

The reproducibility of a method to identify the overuse and underuse of medical procedures

21 January 2018

1 reference

Appropriateness criteria for coronary angiography in angina: reliability and validity.

21 January 2018

1 reference

Use of oral corticosteroids and risk of fractures.

21 January 2018

1 reference

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

21 January 2018

1 reference

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

21 January 2018

1 reference

Management of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease

21 January 2018

1 reference

Clinical utility of dual-energy vertebral assessment (DVA).

21 January 2018

1 reference

Bisphosphonates: a review of their pharmacokinetic properties

21 January 2018

1 reference

Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?

21 January 2018

1 reference

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

21 January 2018

1 reference

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

The skeletal effects of glucocorticoid excess override those of orchidectomy in mice

21 January 2018

1 reference

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

21 January 2018

1 reference

Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment

21 January 2018

1 reference

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids

21 January 2018

1 reference

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

21 January 2018

1 reference

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

What Proportion of Incident Radiographic Vertebral Deformities Is Clinically Diagnosed and Vice Versa?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.362

1 reference

25 August 2017

1 reference